Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars R Olsen

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Science Immunology|December 12, 2025
Heterogeneity of the intestinal mononuclear phagocyte compartment in health and inflammatory bowel diseaseThomas M Fenton, Line Wulff, Venla Väänänen, et al.
Nature Communications|April 24, 2024
Publisher Correction: Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8<sup>+</sup> T cellsMike B Barnkob, Yale S Michaels, Violaine André, et al.
Nature Communications|April 12, 2024
Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8<sup>+</sup> T cellsMike B Barnkob, Yale S Michaels, Violaine André, et al.
Cancer Cell|March 12, 2021
Progressive immune dysfunction with advancing disease stage in renal cell carcinomaDavid A Braun, Kelly Street, Kelly P Burke, et al.
The Journal of Clinical Investigation|July 1, 2022
Reversal of viral and epigenetic HLA class I repression in Merkel cell carcinomaPatrick C Lee, Susan Klaeger, Phuong M Le, et al.
Nature|February 5, 2025
A neoantigen vaccine generates antitumour immunity in renal cell carcinomaDavid A Braun, Giorgia Moranzoni, Vipheaviny Chea, et al.
Nature|December 21, 2018
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trialDerin B Keskin, Annabelle J Anandappa, Jing Sun, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Science Immunology|December 12, 2025
Heterogeneity of the intestinal mononuclear phagocyte compartment in health and inflammatory bowel diseaseThomas M Fenton, Line Wulff, Venla Väänänen, et al.
Nature Communications|April 24, 2024
Publisher Correction: Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8<sup>+</sup> T cellsMike B Barnkob, Yale S Michaels, Violaine André, et al.
Nature Communications|April 12, 2024
Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8<sup>+</sup> T cellsMike B Barnkob, Yale S Michaels, Violaine André, et al.
Cancer Cell|March 12, 2021
Progressive immune dysfunction with advancing disease stage in renal cell carcinomaDavid A Braun, Kelly Street, Kelly P Burke, et al.
The Journal of Clinical Investigation|July 1, 2022
Reversal of viral and epigenetic HLA class I repression in Merkel cell carcinomaPatrick C Lee, Susan Klaeger, Phuong M Le, et al.
Nature|February 5, 2025
A neoantigen vaccine generates antitumour immunity in renal cell carcinomaDavid A Braun, Giorgia Moranzoni, Vipheaviny Chea, et al.
Nature|December 21, 2018
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trialDerin B Keskin, Annabelle J Anandappa, Jing Sun, et al.
Pageof 2